← Back to Search

Other

Avocado Mango for Pre-diabetes (AVMa Trial)

N/A
Waitlist Available
Led By Britt Burton-Freeman, Ph.D
Research Sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline-8 weeks
Awards & highlights

AVMa Trial Summary

This trial will study the effects of avocado and mango consumption on vascular function in people with prediabetes. Vascular function will be assessed using measures of blood flow and pressure, and by looking at the blood vessels in the eye. The trial will also explore whether avocado and mango consumption has any benefits for cognitive function and kidney function.

Who is the study for?
This trial is for men and women aged 25-70 with prediabetes, having fasting blood glucose levels between 100-125 mg/dL. Participants should be in good health without major diseases or recent surgeries that could affect the study's results. They shouldn't take medications or supplements that might interfere with outcomes, must not abuse substances, and non-smokers are preferred.Check my eligibility
What is being tested?
The study tests how eating avocados and mangos affects vascular function over 8 weeks compared to a control diet. It measures changes in artery flexibility, blood pressure, eye vessel health using OCTA technology, cognitive performance through specific tasks, and kidney function indicators.See study design
What are the potential side effects?
While the trial does not focus on side effects of avocado and mango consumption directly, potential side effects may include digestive discomfort or food-related allergies for those sensitive to these fruits.

AVMa Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline-8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline-8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in Central Blood pressure
Changes in Kidney function markers
Changes in Pulse Wave Velocity
+9 more
Secondary outcome measures
Changes in Cognitive Function
Changes in Cognitive Function-1
Changes in Cognitive Function-2
+7 more

AVMa Trial Design

2Treatment groups
Experimental Treatment
Group I: Control meal planExperimental Treatment1 Intervention
2 meals and snacks per day, without avocado and mango, covering 75% of daily calories needs
Group II: Avocado mango meal planExperimental Treatment1 Intervention
2 meals and snacks per day, including 1 avocado + 1 cup of mango, covering 75% of daily calories needs,

Find a Location

Who is running the clinical trial?

Clinical Nutrition Research Center, Illinois Institute of TechnologyLead Sponsor
53 Previous Clinical Trials
2,840 Total Patients Enrolled
Hass Avocado BoardOTHER
12 Previous Clinical Trials
681 Total Patients Enrolled
National Mango BoardOTHER
6 Previous Clinical Trials
237 Total Patients Enrolled

Media Library

Avocado mango (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05353790 — N/A
Prediabetes Research Study Groups: Avocado mango meal plan, Control meal plan
Prediabetes Clinical Trial 2023: Avocado mango Highlights & Side Effects. Trial Name: NCT05353790 — N/A
Avocado mango (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05353790 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research include individuals who have surpassed the age of 40?

"This trial is recruiting patients aged 25 to 70. Those below 18 have 198 potential trials and those over 65 have 1040 prospective clinical studies."

Answered by AI

Are individuals currently able to join this medical experiment?

"According to the information hosted on clinicialtrials.gov, this research study is actively recruiting participants. Initially posted on October 11th 2021 and most recently altered on April 25th 2022, recruitment for these trial remains ongoing."

Answered by AI

How extensive is the enrolment process for this trial?

"Affirmative. According to clinicaltrials.gov, this trial is actively recruiting participants and has been since 11th October 2021 (last update 25th April 2022). The research necessitates 80 individuals from one site."

Answered by AI

What are the criteria for individuals to qualify for enrollment in this research project?

"This clinical trial has room for 80 individuals who suffer from vasodilation, aged between 25 and 70 years old. Eligible candidates must be in good physical health with a fasting blood glucose concentration between 100-125mg/dL and a blood pressure of 120-160mmHg (systolic) or 80-100mmHG(diastolic). Additionally, they should abstain from alcohol consumption 24 hours prior to the study visit as well as any medications that may interfere with outcomes. Furthermore, participants need to comply with dietary plans, follow scheduled visits and answer questionnaires; providing blood samples while maintaining an usual physical activity pattern"

Answered by AI

What are the objectives of this clinical investigation?

"The Clinical Nutrition Research Center at the Illinois Institute of Technology, who are sponsoring this trial, have determined that Changes in Plasma Biomarkers and Measures of Inflammation Concentration (IL-6) will be used as the primary outcome measurement over a span of 8 weeks. Secondary outcomes such as changes in Cognitive Function (Wide Range Achievement Test - 4th Edition Reading Subtest), Foveal Avascular Zone area (Microvascular assessment by OCT-A) and Vascular Branch Number (also Microvascular assessment by OCT-A) shall also be evaluated."

Answered by AI

Who else is applying?

What site did they apply to?
Clinical Nutrition Research Center
What portion of applicants met pre-screening criteria?
Met criteria
~23 spots leftby Apr 2025